Cimzia (certolizumab pegol)

pCPA File Number: 21176
Negotiation Status:
Concluded without agreement
Indication(s):
Psoriasis, moderate to severe plaque
Sponsor/Manufacturer:
UCB Canada Inc.
CDA-AMC Project Number:
SR0587-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: